Results 271 to 280 of about 45,189 (317)
Some of the next articles are maybe not open access.
Disease‐modifying antirheumatic drugs
Medicinal Research Reviews, 1985V J, Stecher +3 more
openaire +2 more sources
Slow-acting antirheumatic drugs
Drug and Therapeutics Bulletin, 1993Rheumatoid arthritis (RA) is common and debilitating. It affects approximately 1% of adults in the UK, with a prevalence which increases with age; over the age of 60 years roughly 2% of men and 5% of women are affected.1 Early in the disease most patients will receive analgesics and NSAIDs, which relieve symptoms but do not affect the underlying ...
openaire +1 more source
Evaluating the Antirheumatic Drugs
Annals of Internal Medicine, 1986Excerpt To the editor: The Food and Drug Administration (FDA) has just reported the completion of the first revision of guidelines for the clinical evaluation of nonsteroidal anti-inflammatory and ...
openaire +1 more source
Disease‐modifying antirheumatic drugs
Medical Journal of Australia, 1992M D, Smith, M J, Ahern
openaire +2 more sources
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
[Disease modifying antirheumatic drugs].
Revue medicale suisse, 2014The natural history of rheumatoid arthritis, previously burdened with high morbidity, has been strongly modified by appropriate treatment. Early diagnosis and treatment, and follow-up by a specialist, with the aim to achieve remission or low disease activity, are essential for the functional outcome of patients.
Luong, Ba K, Gabay, C
openaire +2 more sources
Antirheumatic drugs and eicosanoid synthesis
Scandinavian Journal of Rheumatology, 1988E, Moilanen +5 more
openaire +2 more sources